The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee.
Apr 16, 2019
0
489
Clinical trials have shown that cholesterol-lowering statin drugs can significantly reduce the risk of cardiovascular disease in kidney disease patients who are not on dialysis.
Feb 19, 2019
0
17
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs ...
Jan 31, 2019
0
4
Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death. The study, led by researchers ...
Dec 5, 2018
0
5
Medication administration errors leading to death are common with anticoagulants and antibiotics in particular, according to a new study that analysed incidents reported in England and Wales. The most common error category ...
Dec 4, 2018
0
0
From the DNA of nearly 300,000 veterans, scientists have singled out a handful of genetic mutations that not only govern levels of cholesterol, but may also inform the development and use of drugs for cardiovascular disease ...
Oct 1, 2018
0
50
(HealthDay)—Diclofenac initiators have increased cardiovascular risk compared with non-initiators, according to a study published online Sept. 4 in The BMJ.
Oct 1, 2018
0
0
(HealthDay)—For commonly prescribed cardiovascular drugs, there is no evidence that drug prices are influenced by their value, according to a study published in the August issue of Health Affairs.
Sep 17, 2018
0
0
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal ...
Aug 26, 2018
0
1
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.
Apr 17, 2018
1
37
